Drug Topics

JANUARY 15, 2025

The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.

FDA 187

FDA 187

STAT

JANUARY 14, 2025

For the second time in less than a year, the U.S. Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs.

Insurance 143

Insurance 143

IDStewardship

JANUARY 13, 2025

In this article an infectious diseases pharmacist discusses five interesting things to know about sulopenem (Orlynvah). Authored by: Tina Zheng, Pharm.D., BCIDP UNDER CONSTRUCTION Article PostedXXX Sulopenem etzadroxil and probenecid (Orlynvah) was recently approved in October 2024 for the treatment of uncomplicated urinary tract infections (uUTI) caused by Escherichia coli , Klebsiella pneumoniae , or Proteus mirabilis.

Packaging 130

Packaging Labelling FDA 130

Pharmacy Times

JANUARY 10, 2025

As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JANUARY 14, 2025

The FTC released its second interim staff report Tuesday during Chair Lina Khan's final open commission meeting, but declined to indicate whether it would take further legal action.

138

138

Drug Topics

JANUARY 16, 2025

Researchers compared the safety and reactogenicity of simultaneous doses of recombinant zoster vaccine paired with 2 separate types of inactivated influenza vaccines.

Vaccines 187

Vaccines 187

The Checkup by Singlecare

JANUARY 14, 2025

If youre living with diabeteswhether prediabetes , Type 2 diabetes , or Type 1 diabetes then youre probably taking steps to manage your blood glucose levels. Along with regular exercise, sufficient sleep, and taking care of your mental health, following a healthy, balanced meal plan is one of the most effective components of diabetes management. As you focus on maintaining healthy blood sugar levels, being mindful of your carbohydrate intake is likely at the forefront of your mind.

Health and Personal Care Stores 111

Health and Personal Care Stores Grocery Stores Labelling 111

Pharmacy Times

JANUARY 15, 2025

Building on a previous report that revealed corrupt business practices among the big 3 PBMs, a second interim report finds that PBMs heightened prices for important specialty generic drugs to increase their profit margins.

139

139

Fierce Healthcare

JANUARY 13, 2025

As deadly fires continue to rage in Los Angeles, healthcare companies far and wide are stepping up to serve those affected. At least 24 people have died from the fires and dozens remain missing.

136

136

Drug Topics

JANUARY 14, 2025

Rates of chlamydia and syphilis declined in adults taking HIV PrEP.

187

187

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 13, 2025

Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will provide a boost as the industry gathers for one of its largest events of the year. With the acquisition, the pharma giant will get Intra-Cellular’s Caplyta, which is approved to treat schizophrenia and bipolar-related depression.

137

137

PharmaVoice

JANUARY 14, 2025

Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.

113

113

Pharmacy Times

JANUARY 13, 2025

The new Medicare cap limits out-of-pocket drug costs to $2000 annually.

136

136

Fierce Healthcare

JANUARY 14, 2025

The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers and dealers to San Francisco.

131

131

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

JANUARY 15, 2025

There are a lack of data available on the optimal antiviral medication for nonsevere flu.

187

187

STAT

JANUARY 15, 2025

Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P. Morgan Healthcare conference, the announcements include $245 million for Innovaccer, a health care data company that’s increasingly focused on AI, $141 million for Hippocratic AI, a company that develops generative AI agents to help with clinical tasks, and $105 mill

Hospitals 127

Hospitals 127

Pharmaceutical Technology

JANUARY 13, 2025

NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.

Mayo Clinic 110

Mayo Clinic 110

Pharmacy Times

JANUARY 11, 2025

Some patients treated with prolonged courses of oral nirmatrelvir/ritonavir experienced long COVID symptom improvements, while others reported little to no changes in their symptoms.

132

132

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JANUARY 16, 2025

UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior. | UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior.

129

129

Drug Topics

JANUARY 17, 2025

Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.

Compounding 112

Compounding 112

STAT

JANUARY 16, 2025

SAN FRANCISCO — On the first day of the J.P Morgan Healthcare Conference, a small crowd of demonstrators gathered on a corner of Union Square just opposite of the conference’s main venue, the Westin St. Francis hotel.  It was a varied crew — musicians, health care workers, teachers, and others. Steve Zeltzer, a labor journalist and organizer, spoke before the group and held a sign saying, “No more Deny, Delay, Depose,” alluding to words inscribed on the bu

Insurance 119

Insurance 119

Pharmaceutical Technology

JANUARY 10, 2025

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

FDA 105

FDA 105

Pharmacy Times

JANUARY 10, 2025

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

131

131

Fierce Healthcare

JANUARY 15, 2025

The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special telemedicine registration system. Its three-tiered approach could cost telehealth companies over $40,000 to prescribe controlled substances in all 50 states.

Controlled Substances 128

Controlled Substances 128

Drug Topics

JANUARY 14, 2025

RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.

112

112

STAT

JANUARY 15, 2025

In May 2024 , nearly 90% of pharmacies were closed for a day as thousands of pharmacists protested over “over drug shortages, pharmacy closures and fears medications could be sold online, as well as higher pay.” More recently in November 2024 , pharmacy owners voted in favor of cutting hours and stopping home deliveries in a protest over funding.

133

133

Pharmaceutical Technology

JANUARY 16, 2025

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult population.

FDA 105

FDA 105

Pharmacy Times

JANUARY 13, 2025

If approved, nipocalimab can treat antibody positive individuals with generalized myasthenia gravis.

FDA 123

FDA 123

Fierce Healthcare

JANUARY 13, 2025

A recent confluence of events marks the first time in decades that there's been indication of real, meaningful change to the system, writes Blue Shield of California's Matthew Gibbs.

127

127

Drug Topics

JANUARY 13, 2025

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

112

112

STAT

JANUARY 13, 2025

Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project , a database of genetic data that is expected to accelerate personalized medicine and help discover new drugs.  Truveta plans to use leftover biospecimens from patients — after they consent — receiving routine health care at participating health systems to create the database.

Medical Records 136

Medical Records Pharmaceutical Companies Pharmaceutical Companies Hospitals 136

Pharmaceutical Technology

JANUARY 14, 2025

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

105

105

Pharmacy Times

JANUARY 14, 2025

Brentuximab vedotin is approved for treatment of adult and pediatric with classical Hodgkin lymphoma in combination with chemotherapy.

Chemotherapy 118

Chemotherapy 118